Zithromac Iv Special Investigation For Legionella Infection.

Trial Profile

Zithromac Iv Special Investigation For Legionella Infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Community-acquired pneumonia; Legionnaires' disease; Pelvic inflammatory disorders
  • Focus Therapeutic Use
  • Acronyms RESCUE-L
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 21 Nov 2016 Planned End Date changed from 1 Jan 2017 to 1 Dec 2016.
    • 09 Feb 2016 Planned End Date changed from 1 Feb 2016 to 1 Jan 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top